Literature DB >> 8459998

Color Doppler velocimetry of the optic nerve head in arterial occlusion.

T H Williamson1, G M Baxter, G N Dutton.   

Abstract

BACKGROUND: Color Doppler velocimetry allows simultaneous imaging by B-scan and Doppler ultrasound. This facilitates estimation of blood velocity in the orbital vessels. A pulse arterial waveform providing blood velocity measurements can be obtained from the optic nerve head. The vascular pattern in this region consists of multiple peripapillary blood vessels and a central artery. The exact contribution of the arteries in this area to velocimetry readings was undetermined.
METHODS: In this study, the arterial pulses at the optic nerve head of seven patients with central retinal artery occlusion (CRAO) and seven with anterior ischemic optic neuropathy (AION) were examined by color Doppler velocimetry.
RESULTS: No velocimetric measurements were obtainable at the optic nerve head in three of four patients with acute CRAO (examined within 24 hours of onset) despite color recordings obtainable in the peripapillary region. In contrast, all patients with AION showed characteristic arterial pulse waveforms from the artery that was situated centrally in the optic nerve. No peripapillary color indices were detectable in three of the four patients with ischemic optic neuropathy who were examined within 24 hours of onset of their symptoms. Follow-up investigation showed that there was reperfusion of both arterial circulations within 1 week.
CONCLUSION: The results demonstrate that color Doppler ultrasound of the optic nerve head provides velocimetric measurements of blood flow in the central retinal artery. Although some investigators using different apparatuses have produced velocimetry measurements from the posterior ciliary arteries, in this study reliable measurements were not obtainable form color indices in the peripapillary area.

Entities:  

Mesh:

Year:  1993        PMID: 8459998     DOI: 10.1016/s0161-6420(93)31649-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy.

Authors:  M Kaup; N Plange; K O Arend; A Remky
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

Review 2.  Ocular blood flow measurement.

Authors:  T H Williamson; A Harris
Journal:  Br J Ophthalmol       Date:  1994-12       Impact factor: 4.638

3.  Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities.

Authors:  T H Williamson; G D Lowe; G M Baxter
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

4.  The influence of primary open-angle glaucoma upon the retrobulbar circulation: baseline, postoperative and reproducibility analysis.

Authors:  J R Trible; V P Costa; R C Sergott; G L Spaeth; M Smith; R P Wilson; L J Katz; M R Moster; C M Schmidt
Journal:  Trans Am Ophthalmol Soc       Date:  1993

5.  [Quantification of fluorescein angiography in patients with non-arteritic anterior ischemic optic neuropathy].

Authors:  T Hirsch; A Remky; N Plange; M Kaup
Journal:  Ophthalmologe       Date:  2011-08       Impact factor: 1.059

6.  Orbital color Doppler imaging of optic nerve tumors.

Authors:  C Jacquemin; T Bosley; P Mullaney
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

7.  Comparison of flow velocity of ophthalmic artery between primary open angle glaucoma and normal tension glaucoma.

Authors:  Y Yamazaki; F Hayamizu
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

8.  A comparison of colour Doppler imaging of orbital vessels and other methods of blood flow assessment.

Authors:  T H Williamson; G M Baxter; A Pyott; W Wykes; G N Dutton
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-02       Impact factor: 3.117

9.  Acute Effect of Hypervolemic Hemodilution on Retrobulbar Hemodynamics in Anterior Ischemic Optic Neuropathy.

Authors:  Marion Bienert; Niklas Plange; Andreas Remky; Kay Oliver Arend; David Kuerten
Journal:  Biomed Res Int       Date:  2018-02-06       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.